Description
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California, and it serves more than 140 countries. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets.
Illumina's technology had purportedly reduced the cost of sequencing a human genome to US$1,000 by 2014. Its customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.
